Administration of therapy
| Treatment outcome after 4 × PVAG Treatment outcome after chemotherapy . | CR/CRu . | PR . | NC/progression . | Foregoing discontinuation, unknown* . | Total . | ||||
|---|---|---|---|---|---|---|---|---|---|
| CR/CRu . | PR . | NC/progression . | Foregoing discontinuation, unknown . | NC/progression . | Foregoing discontinuation, unknown . | ||||
| No. of cycles | |||||||||
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 4 |
| 5 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| 6 | 10 | 1 | 3 | 0 | 2 | 0 | 0 | 0 | 16 |
| 8 | 1 | 22 | 8 | 2 | 3 | 2 | 0 | 0 | 38 |
| Radiotherapy | |||||||||
| No | 11 | 22 | 3 | 2 | 3 | 2 | 1 | 4 | 48 |
| Yes | 0 | 1 | 8 | 0 | 2 | 0 | 0 | 0 | 11 |
| Total | 11 | 23 | 11 | 2 | 5 | 2 | 1 | 4 | 59 |
| Treatment outcome after 4 × PVAG Treatment outcome after chemotherapy . | CR/CRu . | PR . | NC/progression . | Foregoing discontinuation, unknown* . | Total . | ||||
|---|---|---|---|---|---|---|---|---|---|
| CR/CRu . | PR . | NC/progression . | Foregoing discontinuation, unknown . | NC/progression . | Foregoing discontinuation, unknown . | ||||
| No. of cycles | |||||||||
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 4 |
| 5 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| 6 | 10 | 1 | 3 | 0 | 2 | 0 | 0 | 0 | 16 |
| 8 | 1 | 22 | 8 | 2 | 3 | 2 | 0 | 0 | 38 |
| Radiotherapy | |||||||||
| No | 11 | 22 | 3 | 2 | 3 | 2 | 1 | 4 | 48 |
| Yes | 0 | 1 | 8 | 0 | 2 | 0 | 0 | 0 | 11 |
| Total | 11 | 23 | 11 | 2 | 5 | 2 | 1 | 4 | 59 |
The final treatment outcome is as follows: CR, 46 (78%); PR, 2 (3.4%); NC, 2 (3.4%); progression, 4 (6.8%); and unknown, 5 (8.5%).
CRu indicates CR uncertain.
Restaging was not performed or patient dropped out of protocol treatment before restaging for known reasons other than “protocol violation.”